lzrse-col7a1 engineered autologous epidermal sheets
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 5, 2010 (NCT01263379)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lzrse-col7a1 engineered autologous epidermal sheets
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01263379 | Phase 1/Phase 2 (Phase 2) | Oct 5, 2010 | Abeona Therapeutics, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stanford University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abeona Therapeutics | For profit | 1 | 0 | 1 | 2010 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Government | 1 | 0 | 1 | 2010 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2010 |
3 organizations
Page 1 / 1